
Overview
Attributes


Advantages
Membership Benefits

Producing monthly updates and targeted insights on developments that affect cell and gene therapies, Megan West and a multidisciplinary team keep you informed by monitoring policy and regulatory changes with strategic business impacts.
Cell & Gene Policy 360 highlights guidance from the FDA, coding and reimbursement developments in the inpatient and outpatient settings of care, regulatory flexibilities for value-based arrangements, drug pricing proposals, and other timely developments.